Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
Technology
E-050-2014
Patent ID
E-050-2014-0-CN-09
Country
CN
Application Type
National Stage
Patent Status
Pending
Patent Number
Publication Number
CN106232807A
Application Number
201480074163.2
IC
NCI
Date Filed
Date Issued
Patent PDF